183 related articles for article (PubMed ID: 24571310)
1. BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression.
Shen H; Chen Z; Ding X; Qi X; Cen J; Wang Y; Yao L; Chen Y
J Cell Mol Med; 2014 Jun; 18(6):1004-17. PubMed ID: 24571310
[TBL] [Abstract][Full Text] [Related]
2. Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells.
Sengupta A; Ficker AM; Dunn SK; Madhu M; Cancelas JA
Blood; 2012 Jan; 119(2):494-502. PubMed ID: 22101899
[TBL] [Abstract][Full Text] [Related]
3. RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes.
Harada Y; Inoue D; Ding Y; Imagawa J; Doki N; Matsui H; Yahata T; Matsushita H; Ando K; Sashida G; Iwama A; Kitamura T; Harada H
Blood; 2013 Apr; 121(17):3434-46. PubMed ID: 23471304
[TBL] [Abstract][Full Text] [Related]
4. The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells.
Mourgues L; Imbert V; Nebout M; Colosetti P; Neffati Z; Lagadec P; Verhoeyen E; Peng C; Duprez E; Legros L; Rochet N; Maguer-Satta V; Nicolini FE; Mary D; Peyron JF
Leukemia; 2015 Oct; 29(10):1993-2002. PubMed ID: 25925206
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.
Xu F; Yang R; Wu L; He Q; Zhang Z; Zhang Q; Yang Y; Guo J; Chang C; Li X
Cancer Lett; 2012 Apr; 317(1):33-40. PubMed ID: 22120066
[TBL] [Abstract][Full Text] [Related]
6. BMI1 gene expression in myeloid leukemias and its impact on prognosis.
Saudy NS; Fawzy IM; Azmy E; Goda EF; Eneen A; Abdul Salam EM
Blood Cells Mol Dis; 2014 Dec; 53(4):194-8. PubMed ID: 25084695
[TBL] [Abstract][Full Text] [Related]
7. Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia.
Zhang X; Yang L; Liu X; Nie Z; Wang X; Pan Y; Luo J
Br J Haematol; 2017 Sep; 178(5):728-738. PubMed ID: 28480959
[TBL] [Abstract][Full Text] [Related]
8. Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells.
Alitalo R; Partanen J; Pertovaara L; Hölttä E; Sistonen L; Andersson L; Alitalo K
Blood; 1990 May; 75(10):1974-82. PubMed ID: 2159816
[TBL] [Abstract][Full Text] [Related]
9. Acetylation-dependent nuclear arrangement and recruitment of BMI1 protein to UV-damaged chromatin.
Sustáčková G; Kozubek S; Stixová L; Legartová S; Matula P; Orlova D; Bártová E
J Cell Physiol; 2012 May; 227(5):1838-50. PubMed ID: 21732356
[TBL] [Abstract][Full Text] [Related]
10. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
[TBL] [Abstract][Full Text] [Related]
11. Phospho-acetylation of histone H3 in the amygdala after acute lithium chloride.
Kwon B; Houpt TA
Brain Res; 2010 May; 1333():36-47. PubMed ID: 20346924
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
[TBL] [Abstract][Full Text] [Related]
13. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
[TBL] [Abstract][Full Text] [Related]
14. Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.
Xu F; Liu L; Chang CK; He Q; Wu LY; Zhang Z; Shi WH; Guo J; Zhu Y; Zhao YS; Gu SC; Fei CM; Li X
Oncotarget; 2016 Feb; 7(7):8119-30. PubMed ID: 26812882
[TBL] [Abstract][Full Text] [Related]
15. Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia.
Li Z; Luo J
Biochem Biophys Res Commun; 2018 Jun; 501(1):64-72. PubMed ID: 29704505
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
17. MDR1 mediated chemoresistance: BMI1 and TIP60 in action.
Banerjee Mustafi S; Chakraborty PK; Naz S; Dwivedi SK; Street M; Basak R; Yang D; Ding K; Mukherjee P; Bhattacharya R
Biochim Biophys Acta; 2016 Aug; 1859(8):983-93. PubMed ID: 27295567
[TBL] [Abstract][Full Text] [Related]
18. P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors.
Brusa G; Zuffa E; Mancini M; Benvenuti M; Calonghi N; Barbieri E; Santucci MA
Br J Haematol; 2006 Feb; 132(3):359-69. PubMed ID: 16409301
[TBL] [Abstract][Full Text] [Related]
19. PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia.
Zhiyong C; Wentong L; Xiaoyang Y; Ling P
Med Oncol; 2012 Jun; 29(2):1084-92. PubMed ID: 21360018
[TBL] [Abstract][Full Text] [Related]
20. [Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell].
Meng YS; Ma XX; Meng XQ; Wei R; Liu W; Ai GW; Zhang YX
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3406-10. PubMed ID: 18476539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
